Cargando…

High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats

Isolated α,β-dehydromonacolin S (C5) from soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178 was recently shown to exhibit an inhibitory effect against 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) activity in vitro. In this study, we investigated the effects of C5 on lipid-lowering,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaewmalee, Jutatip, Ontawong, Atcharaporn, Duangjai, Acharaporn, Tansakul, Chittreeya, Rukachaisirikul, Vatcharin, Muanprasat, Chatchai, Srimaroeng, Chutima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073358/
https://www.ncbi.nlm.nih.gov/pubmed/33920678
http://dx.doi.org/10.3390/ph14040375
_version_ 1783684111854993408
author Kaewmalee, Jutatip
Ontawong, Atcharaporn
Duangjai, Acharaporn
Tansakul, Chittreeya
Rukachaisirikul, Vatcharin
Muanprasat, Chatchai
Srimaroeng, Chutima
author_facet Kaewmalee, Jutatip
Ontawong, Atcharaporn
Duangjai, Acharaporn
Tansakul, Chittreeya
Rukachaisirikul, Vatcharin
Muanprasat, Chatchai
Srimaroeng, Chutima
author_sort Kaewmalee, Jutatip
collection PubMed
description Isolated α,β-dehydromonacolin S (C5) from soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178 was recently shown to exhibit an inhibitory effect against 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) activity in vitro. In this study, we investigated the effects of C5 on lipid-lowering, hepatic steatosis, and hepatic gluconeogenesis in vivo. The control rats received a daily dose of either vehicle or C5 at 10 mg/kg, while the high-fat diet-induced obese (HFD) rats were administered vehicle; 1, 3, or 10 mg/kg C5; or 10 mg/kg lovastatin (LO) for 6 weeks. C5 significantly improved dyslipidemia and diminished liver enzymes, HMGR activity, insulin resistance, and hepatic steatosis, comparable to LO without any hepatotoxicity and nephrotoxicity in HFD rats. A higher efficacy of C5 in lipid-lowering activity and anti-hepatic steatosis was associated with a significant decrease in genes involved in lipid metabolism including sterol regulatory element binding protein (SREBP) 1c, SREBP2, liver X receptor alpha (LXRα), and peroxisome proliferator-activated receptor (PPAR) gamma (PPARγ) together with an increase in the PPAR alpha (PPARα). Correspondingly, C5 was able to down-regulate the lipid transporters cluster of differentiation 36 (CD36) and Niemann-Pick C1 Like 1 (NPC1L1), increase the antioxidant superoxide dismutase gene expression, and decrease the proinflammatory cytokines, tumor necrosis factor alpha (TNFα) and interleukin 1 beta (IL-1β). Impairment of hepatic gluconeogenesis and insulin resistance in HFD rats was restored by C5 through down-regulation of the gluconeogenic genes phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase), and the activation of AMP-dependent kinase serine (AMPK) and serine/threonine protein kinase B (Akt). Collectively, this novel C5 may be a therapeutic option for treating dyslipidemia, hepatic steatosis, and reducing potential risk for diabetes mellitus.
format Online
Article
Text
id pubmed-8073358
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80733582021-04-27 High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats Kaewmalee, Jutatip Ontawong, Atcharaporn Duangjai, Acharaporn Tansakul, Chittreeya Rukachaisirikul, Vatcharin Muanprasat, Chatchai Srimaroeng, Chutima Pharmaceuticals (Basel) Article Isolated α,β-dehydromonacolin S (C5) from soil-derived fungus Aspergillus sclerotiorum PSU-RSPG178 was recently shown to exhibit an inhibitory effect against 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) activity in vitro. In this study, we investigated the effects of C5 on lipid-lowering, hepatic steatosis, and hepatic gluconeogenesis in vivo. The control rats received a daily dose of either vehicle or C5 at 10 mg/kg, while the high-fat diet-induced obese (HFD) rats were administered vehicle; 1, 3, or 10 mg/kg C5; or 10 mg/kg lovastatin (LO) for 6 weeks. C5 significantly improved dyslipidemia and diminished liver enzymes, HMGR activity, insulin resistance, and hepatic steatosis, comparable to LO without any hepatotoxicity and nephrotoxicity in HFD rats. A higher efficacy of C5 in lipid-lowering activity and anti-hepatic steatosis was associated with a significant decrease in genes involved in lipid metabolism including sterol regulatory element binding protein (SREBP) 1c, SREBP2, liver X receptor alpha (LXRα), and peroxisome proliferator-activated receptor (PPAR) gamma (PPARγ) together with an increase in the PPAR alpha (PPARα). Correspondingly, C5 was able to down-regulate the lipid transporters cluster of differentiation 36 (CD36) and Niemann-Pick C1 Like 1 (NPC1L1), increase the antioxidant superoxide dismutase gene expression, and decrease the proinflammatory cytokines, tumor necrosis factor alpha (TNFα) and interleukin 1 beta (IL-1β). Impairment of hepatic gluconeogenesis and insulin resistance in HFD rats was restored by C5 through down-regulation of the gluconeogenic genes phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase), and the activation of AMP-dependent kinase serine (AMPK) and serine/threonine protein kinase B (Akt). Collectively, this novel C5 may be a therapeutic option for treating dyslipidemia, hepatic steatosis, and reducing potential risk for diabetes mellitus. MDPI 2021-04-17 /pmc/articles/PMC8073358/ /pubmed/33920678 http://dx.doi.org/10.3390/ph14040375 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kaewmalee, Jutatip
Ontawong, Atcharaporn
Duangjai, Acharaporn
Tansakul, Chittreeya
Rukachaisirikul, Vatcharin
Muanprasat, Chatchai
Srimaroeng, Chutima
High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats
title High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats
title_full High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats
title_fullStr High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats
title_full_unstemmed High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats
title_short High-Efficacy α,β-Dehydromonacolin S Improves Hepatic Steatosis and Suppresses Gluconeogenesis Pathway in High-Fat Diet-Induced Obese Rats
title_sort high-efficacy α,β-dehydromonacolin s improves hepatic steatosis and suppresses gluconeogenesis pathway in high-fat diet-induced obese rats
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073358/
https://www.ncbi.nlm.nih.gov/pubmed/33920678
http://dx.doi.org/10.3390/ph14040375
work_keys_str_mv AT kaewmaleejutatip highefficacyabdehydromonacolinsimproveshepaticsteatosisandsuppressesgluconeogenesispathwayinhighfatdietinducedobeserats
AT ontawongatcharaporn highefficacyabdehydromonacolinsimproveshepaticsteatosisandsuppressesgluconeogenesispathwayinhighfatdietinducedobeserats
AT duangjaiacharaporn highefficacyabdehydromonacolinsimproveshepaticsteatosisandsuppressesgluconeogenesispathwayinhighfatdietinducedobeserats
AT tansakulchittreeya highefficacyabdehydromonacolinsimproveshepaticsteatosisandsuppressesgluconeogenesispathwayinhighfatdietinducedobeserats
AT rukachaisirikulvatcharin highefficacyabdehydromonacolinsimproveshepaticsteatosisandsuppressesgluconeogenesispathwayinhighfatdietinducedobeserats
AT muanprasatchatchai highefficacyabdehydromonacolinsimproveshepaticsteatosisandsuppressesgluconeogenesispathwayinhighfatdietinducedobeserats
AT srimaroengchutima highefficacyabdehydromonacolinsimproveshepaticsteatosisandsuppressesgluconeogenesispathwayinhighfatdietinducedobeserats